Vera Therapeutics, Inc. Class A Common Stock

VERANASDAQUSD
32.00 USD
0.02 (0.06%)🟢PRE MARKET (AS OF 05:25 AM EDT)
🟢Market: OPEN

Vera Therapeutics, Inc. Class A Common Stock (VERA) trades at $32.00 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, VERA trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Aug 6, 2026.

Open?$32.65
High?$32.65
Low?$32.00
Prev. Close?$32.02
Volume?28
Avg. Volume?2.5M
VWAP?$32.61
Rel. Volume?0.00x
Bid / Ask
Bid?$27.03 × 100
Ask?$37.67 × 100
Spread?$10.64
Midpoint?$32.35
Valuation & Ratios
Market Cap?2.3B
Shares Out?71.8M
Float?63.0M
Float %?87.7%
P/E Ratio?N/A
P/B Ratio?4.60
EPS?-$5.15
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Employees
339
Market Cap
2.2B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-05-14
Address
2000 SIERRA POINT PARKWAY, SUITE 1200
BRISBANE, CA 94005
Phone: 650-770-0077
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
23
Short Sent.?
46
Piotroski F-Score?0/9Weak
Altman Z-Score?8.38Safe
Confidence?49%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?23.95%Squeeze Risk
Short Interest?15.1M
Days to Cover?5.0
Free Float63.0M
Avg Daily Volume3.0M
Settlement Date2026-07-15
Financial Health
Current Ratio?13.64Strong
Quick Ratio?13.64Strong
Cash Ratio?2.53Strong
Debt/Equity?0.15Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A
P/B?
Peers
100
S&P
39
4.60FAIR
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-5.9CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-74.0%WEAK
ROA?
S&P
3
-59.5%WEAK
Cash Flow & Enterprise
FCF?$-293814000
Enterprise Value?$2.3B
Fundamentals ratios updated end of day